What is Palbociclib?

Category: Prescription Drugs

Most popular types: Ibrance

false

Palbociclib is a medication that may be used as treatment of ER-positive and HER2-negative breast cancer.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Breast cancer 7 8
Bone metastases 3 1
Liver metastasis 1 0
Lung cancer 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
6
Mild
3
None
0

Commonly reported side effects and conditions associated with Palbociclib

Side effect Patients
Canker sores (aphthous ulcer) 1
Constant tiredness 1
Fatigue 1
Hair loss 1
Hot flashes at night 1
Immune system weak 1

Show all 8 reported side effects

Dosages

Based on patients currently taking Palbociclib

Dosage Patients
125 mg daily 8
100 mg daily 1

Duration

Currently taking Palbociclib

Duration Patients
Less than 1 month 1
1 - 6 months 1
6 months - 1 year 3
1 - 2 years 2
2 - 5 years 2
Adherence
Adherence Evaluations
Always 9
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 8
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 2
$25-49 4
< $25 0
Not specified 3

What people switch to and from

Patients started taking Palbociclib after stopping:

Treatment Patients
Exemestane (Aromasin) 2
Carboplatin 1
Chemotherapy 1
Everolimus (Afinitor) 1
Last updated:
There are no evaluations for Palbociclib.